SNCA and Parkinson disease: In order to overcome some of the limitations of the neurotoxin models of PD, attempts have been made to create new models which replicate the progressive nature of the pathology and its α-synuclein basis [55], but this has not really been done to any great extent to look at the survival, integration and functional impact of fetal VM dopaminergic grafts.